Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy

Meglio, Antonio Di; Soldato, Davide; Presti, Daniele; Vaz-Luís, Inês

doi:10.1097/cco.0000000000000781

Cited by 13 publications

(13 citation statements)

References 88 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A significant correlation was observed between a healthy lifestyle and quality of life scores in breast cancer survivors. In similar studies, having a healthy lifestyle, including adequate exercise, proper consumption of fruits and vegetables, weight loss, and satisfactory sleep, effectively improved the quality of life concerning the health of breast cancer survivors [25][26][27][28]. Improving quality of life can also be associated with favorable prognosis and lower mortality in breast cancer survivors [28].…”

Section: Discussionmentioning

confidence: 88%

Evaluating the psychometric properties of the Persian version of the Healthy Lifestyle Instrument for Breast Cancer Survivors (HLI-BCS)

Tabriz

Aledavood²,

Ramezani³

et al. 2023

BMC Women's Health

View full text Add to dashboard Cite

Background Precise examination of breast cancer survivors’ lifestyles can lead to improved planning and implementation of care and counseling interventions to increase their survival rate and improve their quality of life. Therefore, a valid and reliable instrument needs to be developed. Therefore, the present study aimed to determine the psychometric properties of the Persian version of the Healthy Lifestyle Instrument for Breast Cancer Survivors (HLI-BCS). Methods This methodological study was conducted on 420 Iranian breast cancer survivors between May and November 2022. Participants were selected using convenience sampling. The face, content, construct validity, convergent, and reliability of the Persian version of the HLI-BCS were assessed. Results After assessing face, content, and construct validity, the Persian version of the HLI-BCS with five factors and 20 items was provided. The total Cronbach’s alpha and intra-class correlation coefficient (ICC) were calculated as 0.86 and 0.79, respectively, which were at acceptable levels. A healthy lifestyle in breast cancer survivors was observed to have strong and significant relationships with quality of life in general (p < 0.001, r = 0.832), physical health (r = 0.786), and mental health (r = 0.809). Conclusion The Persian version of the HLI-BCS has favorable properties, is consistent with the conditions of breast cancer survivors, and is valid and reliable. This version of the scale can provide adequate and precise information on the lifestyles of these patients.

show abstract

Section: Discussionmentioning

confidence: 88%

Evaluating the psychometric properties of the Persian version of the Healthy Lifestyle Instrument for Breast Cancer Survivors (HLI-BCS)

Tabriz

Aledavood²,

Ramezani³

et al. 2023

BMC Women's Health

View full text Add to dashboard Cite

show abstract

“… 34 Previous studies have used feasibility studies prior to conducting a study in a larger setting. 9 35 The intervention was developed to encourage patients to be more actively involved in their care and well-being as partners with their contact nurse. 10 It has been stated that an intervention could be considered complex due to the behaviours required by those delivering the intervention, 36 that is, a contact nurse.…”

Section: Introductionmentioning

confidence: 99%

“…Other challenges that have been identified include older age,7 medicine costs or a general dislike of taking a regular medicine 8. As ET is a long-lasting treatment, women may request support in managing challenges 9. To manage challenges with ET, a partnership with healthcare professionals could be appropriate, as a previous study10 identified that women with ET want to be able to manage their treatment but need guidance to do so.…”

Section: Introductionmentioning

confidence: 99%

“…A previous study developed a person-centred support programme in collaboration among patients, healthcare professionals, researchers and managers with ET experience10 that needed to be tested in a feasibility study using the Template for Intervention Description and Replication (TIDieR) checklist33 and the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement 34. Previous studies have used feasibility studies prior to conducting a study in a larger setting 9 35. The intervention was developed to encourage patients to be more actively involved in their care and well-being as partners with their contact nurse 10.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study

et al. 2022

View full text Add to dashboard Cite

ObjectiveThe peRson-cEntred Support Programme EndoCrine Therapy intervention is a complex intervention encompassing a person-centred support programme for patients with breast cancer being treated with endocrine therapy (ET). The aim of this study was to explore the feasibility of the trial design and patient acceptability of the intervention and outcome measures and to provide data to estimate the parameters required to design the final intervention.DesignA controlled before-and-after design following the Consolidated Standards of Reporting Trials 2010 statement for feasibility trials.SettingA surgical outpatient clinic in Sweden.ParticipantsForty-one patients (aged 47–85) with breast cancer who were treated with ET.InterventionsEligible patients were assigned to the control group or intervention group, which included individual education material, an individualised learning plan and a personalised reminder letter using a person-centred approach. The intervention could be delivered as a telephone or digital follow-up during a 12-week follow-up.Outcome measuresThe aims were to determine the recruitment rate, assess the rate of retention, explore whether the intervention was delivered according to the protocol, assess the preferred form of educational support, rate of education sessions, length per education session and length between each education session, determine the distribution of education materials and assess completion rates of patient-reported instruments, including the General Self-efficacy Scale, the Quality of Care from the Patient’s Perspective Questionnaire and the Memorial Symptom Assessment Scale.ResultsEighty-six per cent of the patients in the intervention group completed the intervention and questionnaires 3 months after their inclusion. The call attendance was 90%. During the intervention, the contact nurse complied with the intervention protocol. For self-efficacy, symptoms and quality of care, there were no differences in effect size between the control and intervention groups.ConclusionsThis intervention seems to be feasible and acceptable among patients.

show abstract

“…6 Despite the side effects such as night sweats, hot flushes, joint and muscle pain, vaginal dryness, and others being relatively common occurring in up to 70% of patients, personal interpretation of these symptoms and their impact on the patient's quality of life (QoL) widely differ. 7,8 In an advanced BC stage, where the endocrine therapy effect on the disease is more apparent by decreasing metastasis and tumor mass, side effects are better tolerated and therefore lead to only a marginal non-acceptance. 9 On the other hand, in early BC, the benefit of AET cannot be experienced immediately, whereas the side effects may have a direct impact on the QoL.…”

Section: Introductionmentioning

confidence: 99%

The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients

Elfgen

Güth

et al. 2022

Psycho-Oncology

View full text Add to dashboard Cite

Objective: Despite adjuvant endocrine therapy (AET) considerably reducing mortality and recurrence in hormonal receptor-positive (HR+) breast cancer (BC) patients, acceptance of AET remains an issue. The reasoning behind the lack of acceptance is complex and multifactorial, and some associated risk factors have been previously analyzed. Our study aims to assess women's beliefs and concerns toward AET and women's trust in the treating physician, focusing on determining the importance of these factors in the acceptance of AET. Methods: Out of n = 539, n = 269 women with HR + BC participated in a crosssectional online survey. The main study variables were AET necessity beliefs and concerns (Beliefs about Medicines Questionnaire) and the trust in treating physicians. A binary hierarchical logistic regression was applied to predict AET acceptance. Results:We did not observe a meaningful mean difference in the necessity beliefs between women who accepted versus refused AET by the time of study conduct.Women with ongoing AET intake indicated significantly higher trust in their treating physician (d = 0.57) and have lower concerns (d = −1.65) regarding AET than women who had declined or discontinued AET prematurely. Results of the logistic regression demonstrated that after adjusting for clinical factors (e.g., prognosis, age), higher trust and lower concerns significantly increased the likelihood of accepting AET treatment. Conclusions:Our results demonstrate the importance of discussing potential concerns regarding AET and establishing a trustful patient-physician relationship, which outweighs non-modifiable factors such as cancer prognosis.

show abstract

Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy

Cited by 13 publications

References 88 publications

Evaluating the psychometric properties of the Persian version of the Healthy Lifestyle Instrument for Breast Cancer Survivors (HLI-BCS)

Evaluating the psychometric properties of the Persian version of the Healthy Lifestyle Instrument for Breast Cancer Survivors (HLI-BCS)

Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study

The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients

Contact Info

Product

Resources

About